- Denning, David W;
- Page, Iain D;
- Chakaya, Jeremiah;
- Jabeen, Kauser;
- Jude, Cecilia M;
- Cornet, Muriel;
- Alastruey-Izquierdo, Ana;
- Bongomin, Felix;
- Bowyer, Paul;
- Chakrabarti, Arunaloke;
- Gago, Sara;
- Guto, John;
- Hochhegger, Bruno;
- Hoenigl, Martin;
- Irfan, Muhammad;
- Irurhe, Nicholas;
- Izumikawa, Koichi;
- Kirenga, Bruce;
- Manduku, Veronica;
- Moazam, Samihah;
- Oladele, Rita O;
- Richardson, Malcolm D;
- Tudela, Juan Luis Rodriguez;
- Rozaliyani, Anna;
- Salzer, Helmut JF;
- Sawyer, Richard;
- Simukulwa, Nasilele F;
- Skrahina, Alena;
- Sriruttan, Charlotte;
- Setianingrum, Findra;
- Wilopo, Bayu AP;
- Cole, Donald C;
- Getahun, Haileyesus
Chronic pulmonary aspergillosis (CPA) is a recognized complication of pulmonary tuberculosis (TB). In 2015, the World Health Organization reported 2.2 million new cases of nonbacteriologically confirmed pulmonary TB; some of these patients probably had undiagnosed CPA. In October 2016, the Global Action Fund for Fungal Infections convened an international expert panel to develop a case definition of CPA for resource-constrained settings. This panel defined CPA as illness for >3 months and all of the following: 1) weight loss, persistent cough, and/or hemoptysis; 2) chest images showing progressive cavitary infiltrates and/or a fungal ball and/or pericavitary fibrosis or infiltrates or pleural thickening; and 3) a positive Aspergillus IgG assay result or other evidence of Aspergillus infection. The proposed definition will facilitate advancements in research, practice, and policy in lower- and middle-income countries as well as in resource-constrained settings.